[HTML][HTML] The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

HH Han, HM Wang, P Jangili, M Li, L Wu… - Chemical Society …, 2023 - pubs.rsc.org
Cancer remains as one of the most significant health problems, with approximately 19
million people diagnosed worldwide each year. Chemotherapy is a routinely used method to …

[HTML][HTML] The JAK/STAT signaling pathway: from bench to clinic

X Hu, J Li, M Fu, X Zhao, W Wang - Signal transduction and targeted …, 2021 - nature.com
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling
pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular …

[HTML][HTML] The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

A Emami Nejad, S Najafgholian, A Rostami… - Cancer Cell …, 2021 - Springer
Hypoxia is a common feature of solid tumors, and develops because of the rapid growth of
the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of …

[HTML][HTML] Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

V Panwar, A Singh, M Bhatt, RK Tonk… - Signal transduction and …, 2023 - nature.com
The mammalian target of rapamycin (mTOR) is a protein kinase that controls cellular
metabolism, catabolism, immune responses, autophagy, survival, proliferation, and …

[HTML][HTML] Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors

L Xu, C Zou, S Zhang, TSM Chu, Y Zhang… - Journal of hematology & …, 2022 - Springer
The development of combination immunotherapy based on the mediation of regulatory
mechanisms of the tumor immune microenvironment (TIME) is promising. However, a deep …

[HTML][HTML] Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

P Jin, J Jiang, L Zhou, Z Huang, EC Nice… - Journal of Hematology & …, 2022 - Springer
Drug resistance represents a major obstacle in cancer management, and the mechanisms
underlying stress adaptation of cancer cells in response to therapy-induced hostile …

[HTML][HTML] Stem cell programs in cancer initiation, progression, and therapy resistance

T Huang, X Song, D Xu, D Tiek, A Goenka, B Wu… - Theranostics, 2020 - ncbi.nlm.nih.gov
Over the past few decades, substantial evidence has convincingly revealed the existence of
cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly …

Genomic and evolutionary classification of lung cancer in never smokers

T Zhang, P Joubert, N Ansari-Pour, W Zhao… - Nature …, 2021 - nature.com
Lung cancer in never smokers (LCINS) is a common cause of cancer mortality but its
genomic landscape is poorly characterized. Here high-coverage whole-genome sequencing …

[HTML][HTML] Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans

IS Kim - Antioxidants, 2021 - mdpi.com
Soybeans are rich in proteins and lipids and have become a staple part of the human diet.
Besides their nutritional excellence, they have also been shown to contain various functional …

[HTML][HTML] Molecular mechanisms of tumor resistance to radiotherapy

Y Wu, Y Song, R Wang, T Wang - Molecular Cancer, 2023 - Springer
Background Cancer is the most prevalent cause of death globally, and radiotherapy is
considered the standard of care for most solid tumors, including lung, breast, esophageal …